Latest advancements and trends in biomedical polymers for disease prevention, diagnosis, treatment, and clinical application
Mingxia Jiang,
No information about this author
Huapan Fang,
No information about this author
Huayu Tian
No information about this author
et al.
Journal of Controlled Release,
Journal Year:
2025,
Volume and Issue:
380, P. 138 - 174
Published: Feb. 5, 2025
Language: Английский
A Minimalist Pathogen‐Like Sugar Nanovaccine for Enhanced Cancer Immunotherapy
Miao Yu,
No information about this author
Le Niu,
No information about this author
Xinying Lv
No information about this author
et al.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 29, 2024
Pathogen-mimicking
nanoparticles
have
emerged
at
the
forefront
of
vaccine
delivery
technology,
offering
potent
immune
activation
and
excellent
biocompatibility.
Among
these
innovative
carriers,
mannan,
a
critical
component
yeast
cell
walls,
shows
promise
as
an
exemplary
carrier.
Nevertheless,
it
faces
challenges
like
unpredictable
immunogenicity,
rapid
elimination,
limited
antigen
loading
due
to
high
water
solubility.
Herein,
mannan
with
varying
carbon
chain
ratios
is
innovatively
modified,
yielding
series
dodecyl
chains
modified
(Mann-C
Language: Английский
Supramolecular charge-reversal pillar[6]arenes-oxaliplatin system for cancer therapy with reduced toxicity and enhanced efficacy
Journal of Industrial and Engineering Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
Language: Английский
Extracellular Vesicle‐Inspired Minimalist Flexible Nanocapsules Assembled with Whole Active Ingredients for Highly Efficient Enhancement of DC‐Mediated Tumor Immunotherapy
Ao He,
No information about this author
Qiang Li,
No information about this author
Meng Dang
No information about this author
et al.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 25, 2024
The
development
of
nanovaccines
capable
eliciting
tumor-specific
immune
responses
holds
significant
promise
for
tumor
immunotherapy.
However,
many
nanovaccine
designs
rely
heavily
on
incorporating
multiple
adjuvants
and
carriers,
increasing
the
biological
hazards
associated
with
these
additional
components.
Here,
this
work
introduces
novel
flexible
nanocapsules
(OVAnano)
designed
to
mimic
extracellular
vesicles,
primarily
using
ovalbumin
antigen
minimal
polyethylenimine
adjuvant
These
results
show
that
biomimetic
structure
OVAnano
facilitates
enhanced
uptake
by
dendritic
cells
(DCs),
leading
efficient
release
into
cytosol
via
endosomal
escape,
ultimately,
successful
cross-presentation
DCs.
Furthermore,
modulates
intracellular
nuclear
factor
kappa-B
(NF-κB)
signaling
pathway,
promoting
DC
maturation.
highly
purified
antigens
in
demonstrate
remarkable
antigen-specific
immunogenicity,
triggering
strong
antitumor
mediated
Therapeutic
vaccination
studies
have
also
shown
administration
effectively
suppresses
growth
mice
inducing
from
CD8
Language: Английский